Filed: 2/14/2023ACC: 0000905148-23-000261
📋 What this filing means
VENBIO PARTNERS LLC filed this quarterly 13F‑HR report disclosing 7 equity positions with a total reported market value of $322.54M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
7
Positions
$322.54M
Total AUM (reported)
21.50M
Total Shares
Allocation by class
COM$322.54M100.0%
Portfolio Concentration
Top 3$279.87M86.8%
4–10$42.67M13.2%
Top 3 weight
86.8%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 21.50M
Sole
Full voting authority
21.50M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole7
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings7
Rows:
VENTYX BIOSCIENCES INC
SOLEShares3.46M
TypeSH
Market value$113.50M
35.19%
Sole
3.46M
Shared
0.00
None
0.00
ALX ONCOLOGY HLDGS INC
SOLEShares9.70M
TypeSH
Market value$109.32M
33.89%
Sole
9.70M
Shared
0.00
None
0.00
HARMONY BIOSCIENCES HLDGS IN
SOLEShares1.04M
TypeSH
Market value$57.05M
17.69%
Sole
1.04M
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares2.30M
TypeSH
Market value$25.84M
8.01%
Sole
2.30M
Shared
0.00
None
0.00
IMPEL PHARMACEUTICALS INC
SOLEShares2.76M
TypeSH
Market value$10.35M
3.21%
Sole
2.76M
Shared
0.00
None
0.00
CINCOR PHARMA INC
SOLEShares383.39K
TypeSH
Market value$4.71M
1.46%
Sole
383.39K
Shared
0.00
None
0.00
ELEVATION ONCOLOGY INC
SOLEShares1.87M
TypeSH
Market value$1.77M
0.55%
Sole
1.87M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
VENTYX BIOSCIENCES INCSOLE | COM | 3.46M | SH | $113.50M 35.19% | 3.46M | 0.00 | 0.00 |
ALX ONCOLOGY HLDGS INCSOLE | COM | 9.70M | SH | $109.32M 33.89% | 9.70M | 0.00 | 0.00 |
HARMONY BIOSCIENCES HLDGS INSOLE | COM | 1.04M | SH | $57.05M 17.69% | 1.04M | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 2.30M | SH | $25.84M 8.01% | 2.30M | 0.00 | 0.00 |
IMPEL PHARMACEUTICALS INCSOLE | COM | 2.76M | SH | $10.35M 3.21% | 2.76M | 0.00 | 0.00 |
CINCOR PHARMA INCSOLE | COM | 383.39K | SH | $4.71M 1.46% | 383.39K | 0.00 | 0.00 |
ELEVATION ONCOLOGY INCSOLE | COM | 1.87M | SH | $1.77M 0.55% | 1.87M | 0.00 | 0.00 |